UR-2922
UR-2922 is a platelet GPIIb/IIIa antagonist with antiplatelet aggregation and cardiovascular disease inhibition activities. UR-2922 has high affinity for human platelet receptors and has good pharmacokinetic properties, and can be used to inhibit cardiovascular diseases.
Product Specifications
CAS Number
[220386-56-1]
UNSPSC
12352005
Target
Integrin
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ur-2922.html
Smiles
O=C(CN1N=C2C(CN(CC2)C([C@H](CC3=CC=C(C=C3)[N+]([O-])=O)NC(C4=CC=C(C=C4)C(N)=N)=O)=O)=C1)O
Molecular Formula
C25H25N7O6
Molecular Weight
519.51
References & Citations
[1]UR-3216: a new generation oral platelet GPIIb/IIIa antagonist
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
